{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:45Z","timestamp":1761663165905},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,10]]},"DOI":"10.1097\/qad.0b013e3283636179","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:50:43Z","timestamp":1369158643000},"page":"2245-2253","source":"Crossref","is-referenced-by-count":20,"title":["The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults"],"prefix":"10.1097","volume":"27","author":[{"given":"Nicola E.","family":"Mackie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dolling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Fearnhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Tilston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00002030-200404090-00008","article-title":"Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.","volume":"18","author":"Grossman","year":"2004","journal-title":"AIDS"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1097\/QAI.0b013e3182364c80","article-title":"Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms.","volume":"58","author":"Frentz","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/135965350000500106","article-title":"Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and preexisting mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.","volume":"5","author":"Balotta","year":"2000","journal-title":"Antivir Ther"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2006.01.012","article-title":"Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.","volume":"36","author":"Vergne","year":"2006","journal-title":"J Clin Virol"},{"key":"R9-11-20210130","first-page":"156","article-title":"2011 update of the drug resistance mutations in HIV-1.","volume":"19","author":"Johnson","year":"2011","journal-title":"Top HIV Med"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences.","volume":"21","author":"de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/1097-0258(20001215)19:23<3171::AID-SIM619>3.0.CO;2-T","article-title":"Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trials.","volume":"19","author":"Hughes","year":"2000","journal-title":"Stat Med"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis.","volume":"18","author":"Van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"Whats wrong with Bonferroni adjustments.","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation.","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/biomet\/asm028","article-title":"Small-sample degrees of freedom for multicomponent significance tests with multiple imputation for missing data.","volume":"94","author":"Reiter","year":"2007","journal-title":"Biometrika"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/135965350300800506","article-title":"Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapy.","volume":"8","author":"Harrigan","year":"2003","journal-title":"Antivir Ther"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/01.qai.0000135958.80919.e4","article-title":"Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individuals.","volume":"37","author":"Smith","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.aids.0000163930.68907.37","article-title":"Rare mutations at codon 103 at HIV-1 reverse transcriptase can confer resistance to nonnucleoside reverse transcriptase inhibitors.","volume":"19","author":"Harrigan","year":"2005","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e3283636179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T23:08:49Z","timestamp":1715382529000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201309100-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":14,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283636179","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,10]]}}}